Abstract

Abstract Background: Human Cytomegalovirus (HCMV) is an endemic herpes virus that re-emerges in cancer patients enhancing oncogenic potential. Recent studies have shown that HCMV infection is associated with certain types of cancer morbidity such as glioblastoma; Although HCMV has been detected in breast cancer tissues. The ability of HCMV to infect diverse organs and cell types in vivo has been attributed to strain variations in certain genes of the virus. The relationship between genetic variants of the envelope glycoprotein genes of HCMV and disease outcome has been studied recently, among these variable genes HCMV ORF UL73 (envelope glycoprotein N). Aims: The aims of the present study were to 1) Screen for the infection of Human cytomegalovirus infection in inflammatory versus non-inflammatory breast cancer patients and 2) test the frequency of occurrence of multiple genotypes of HCMV glycoprotein N in IBC versus Non-IBC patients, to determine if there is any mixed infections by multiple genotypes in paired clinical specimens obtained from patients. Material and Methods: A total 93 (62 Non-IBC and 31 IBC) women diagnosed with breast cancer by clinical examination, ultrasound, mammography, and confirmed by biopsy (tru-cut) were enrolled into this study from Ain Shams university Hospitals. During modified radical mastectomy or conservative breast surgery carcinoma and non carcinoma tissues with peripheral blood were collected to detect the presence of Human cytomegalovirus DNA using nested PCR. HCMV glycoprotein N polymorphism (gN) was detected using multiplex PCR by using specific primers to each gN genotype which enable us to detect any mixed genotypes infection. Results: Analysis of the HCMV nested PCR to the carcinoma tissues showed that 63% of non-IBC carcinoma tissues were HCMV-DNA positive and 37% were HCMV-DNA negative. In IBC 80% of carcinoma tissues were HCMV-DNA positive and 20% were HCMV-DNA negative. Application of multiplex PCR for gN gene on HCMV positive carcinoma tissues (25 IBC and 32 Non-IBC) revealed that gN-1 genotype was detected in 25% of the non-IBC patients and 32% of the IBC patients, While gN-3b was detected in 6.25% of non-IBC patients and 4% of the IBC patients. Genotype gN-4a was detected in 9.38% of Non-IBC patients and in 4% of the IBC patients, while gN-4b\c was detected in 59.37% of Non-IBC patients and in 60% of the IBC patients. Also revealed mixed infection of gN-1+ gN-4b\c, gN-3b + gN-4b\c and gN-4a + gN-4b\c in Non-IBC patients and gN-1+ gN-4b\c, gN-3b + gN-4b\c in IBC patients. Conclusion: The frequency of HCMV infection in IBC was higher than Non-IBC patients; however the most dominant HCMV gN genotypes in IBC and Non-IBC are similar. Citation Format: Hossam Taha Mohamed, Mohamed El-Shinawi, Islam A. El-Ghonaimy, Abdel-Rahman Bashtar, El-Said Tarek abdel Salam, Robert J. Schneider, Mona Mostafa Mohamed. Detection of different genotypes of Human Cytomegalovirus in breast cancer patients. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4788. doi:10.1158/1538-7445.AM2013-4788 Note: This abstract was not presented at the AACR Annual Meeting 2013 because the presenter was unable to attend.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call